Mymetics Corp (MYMX)

[Harry Wickey]

From 10K again,

"Next steps: (from 10K HIV study)
Towards the end of March 2016 we will obtain the results of the non-human primate study. A successful study will trigger a phase where the mechnisms of protection will be analyzed and also start the planning of the clinical trial development for the Mymetics HIV vaccine candidate, building on the previous Phase I that already showed a good safety and tolerance profile and the induction of mucosal and humoral antibodies. Funding for the clinical trial development will be sought from partners and grant funding organizations. A combined Phase I/II on women and men might start by the end 2016 and an eventual market launch anticipated in 2025."